Helping patients find the breast cancer
resources they deserve

How do we help breast cancer patients?

Massive Bio offers an independent cancer treatment analysis as well as free clinical trial matching for breast cancer patients. Our patient advocates work closely with patients to gather information on their current medical status, and then will provide a list of options from available cancer clinical trials close to your home.

We can also provide a comprehensive case analysis through our Virtual Tumor Board from cancer specialists. The Virtual Tumor Board (VTB) is comprised of highly specialized oncologists from nationally-recognized Cancer Centers of Excellence. In just 7-10 days after receiving your medical records, we can get you a treatment plan without having to travel far distances and use your valuable time.


Clinical Trials

There are approximately 958 breast cancer clinical trials that are currently recruiting patients in the United States right now. With such an extensive list, many of them could be beneficial for you. Our team of patient advocates, who are oncology nurses, and our artificial intelligence based clinical trial matching system will find the best option for you.

A Study of TAS-120 in Patients With Metastatic Breast Cancer and FGFR amplification.

With just a few clicks, you can see your clinical trial matches now. Click here to use our advanced clinical trial match tool.

Breast Cancer Facts

It is the second most common cancer type for women with 12.8% of women being diagnosed throughout their life. Even though most people think of women when it comes to breast cancer, roughly 1% of patients are male. Over 268,000 new cases last year alone. 67% of breast cancer patients have the subtype HR+/HER2, which makes it the most common by far considering the next most common subtype being HR-/HER2, which includes about 10% of the patient population.

Causes

The breast cancer cells typically begin growing in the milk-producing ducts. Family history does play a role in breast cancer through gene mutations. Radiation exposure, obesity, and never being pregnant have all been linked to increasing one’s chance at getting breast cancer. Women represent roughly 99% of the breast cancer population, so being female is also an inherent risk factor.

Treatments

The common treatment methods for cancer patients include surgery, radiation therapy, chemotherapy, hormone therapy, targeted therapy, immunotherapy. Oncologists determine the appropriate method of treatment based on the stage and genetic mutations of this type of cancer.

Screening

By far the most common type of screening is a mammogram. For those who have a family history or at a high risk of breast cancer, MRI’s are also used. Other screening methods that are currently being utilized within clinical trials are breast exams, thermography, and tissue sampling.

Trends

The number of cases of breast cancer have increased slightly since 1975. The number of cases went from 105 per 100,000 to 129 per 100,000 in 2016. Even though the amount of patients have increased, the amount of deaths have decreased steadily from 31 to 20 per 100,000. This means progress has been made in the overall treatment of breast cancer, but not in the prevention of it.

Subtypes

Luminal A
Luminal B
Triple negative/basal-like
HER2-enriched

Support

Our team of patient advocates can help guide you to treatment options you might not have been previously aware of. Although you might be new to cancer, we certainly are not. Navigating cancer patients through the tricky path of finding the best treatment is our goal. No two cancer patients are alike, which is why we find treatment for all of our patients based on their specific genomics, location, stage of cancer, and nearly 100 more data points.

Learn Your Breast Cancer
Clinical Trial and Treatment Options